Jutro Medical Raises €36M Series A To Expand AI-Enabled Primary Care
Dec 16, 2025 | By Kailee Rainse

Warsaw-based Jutro Medical, an AI-first primary care operator combining online and in-person care, has raised €24 million in new funding, led by Warsaw Equity Group, with participation from Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC.
SUMMARY
- Warsaw-based Jutro Medical, an AI-first primary care operator combining online and in-person care, has raised €24 million in new funding, led by Warsaw Equity Group, with participation from Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC.
The round also includes a debt component from mBank and Orbit Capital, bringing the total amount raised in the company’s previously announced Series A to €36 million.
Founded in 2020, Jutro Medical has expanded from a single clinic focused on technology-enabled care to an integrated primary care operator with its own electronic health record (EHR), standardised clinic operations, and AI-based tools.
In its first four years, Jutro Medical concentrated on building a proprietary EHR and the software and data infrastructure used across its clinics.
Read Also - Freestyle Football Star Raises Nearly £1M To Expand ‘Focus’ Supplement HP-1
This foundation has allowed the company to more efficiently integrate an AI layer, which supports administrative tasks like intake and visit documentation drafting.
Clinicians begin appointments with the relevant context prepared, review and adjust information as needed and retain responsibility for all clinical decisions. Patients can choose whether to use AI during their appointment, with the option for a traditional approach.
Jutro Medical’s model addresses broader challenges in primary care, such as workforce shortages, rising administrative workloads, and inconsistent access to care. Despite over €200 billion in annual primary care spending across Europe (including €9 billion in Poland), many clinics still rely on manual or paper-based processes that delay access to care.
The company follows an acquisition-led strategy, bringing acquired clinics onto a shared operating and technology platform, including a common EHR, workflows, and AI tools.
Jutro Medical added nine clinics to its network this year and aims to acquire around 20 clinics annually to ensure more consistent service delivery and faster integration.
By running our own clinics on our own software, we’ve learned firsthand which tasks can be handled by AI. Instead of hiring more staff, we now build AI agents that do the same work – freeing clinicians to practice medicine, not paperwork. These agents already manage thousands of patients interactions every month, says Adam Janczewski, founder and CEO of Jutro Medical.
The new funding will fuel Jutro Medical’s clinic acquisitions in Poland and support expansion into other European markets.
The company will further develop AI agents to automate administrative and operational tasks, allowing clinicians to focus on diagnosis and treatment. Long-term Jutro Medical aims to become a pan-European primary care operator by consolidating fragmented small practices.









